Doctors typically divide small cell lung cancer (SCLC) into limited or extensive stages, depending on whether the cancer is in one lung, both lungs, or has spread to distant areas. Staging for small ...

Stage 3 prostate cancer is locally advanced, with tumors extending beyond the prostate but not metastasizing distantly.

Stage III oral cavity cancer is characterized by larger tumors or lymph node involvement, often diagnosed through physical ...

Oropharyngeal cancer is the most common type of throat cancer. After your diagnosis, you will learn the stage of the cancer. The stage lets you know how far, if at all, the cancer has spread from the ...

There are four stages of laryngeal cancer. They are slightly different depending on where in your larynx the cancer starts. Laryngeal cancer happens when abnormal (cancerous) cells start to grow in ...

Alongside high tumor marker levels, stage 3 testicular cancer has either spread to distant areas or nearby lymph nodes. The most common treatment options are surgery and chemotherapy. Stage 3 ...

This fact sheet explains how lung cancer is staged, and what each stage means. Lung cancer staging can be complex, but this fact sheet is intended for patient education. Our easy-to-read fact sheets ...

The new Sassun-Mayo staging system, which integrates tumor deposit and lymph node counts, improves prognostic accuracy for patients with colon cancer compared with the standard American Joint ...

The extent of the bladder cancer — how far it has spread — matters. Your care team needs to know if your cancer sits on or in the first lining of your bladder (non-muscle invasive), if it goes into ...

Staging of patients with early pancreatic cancer is inaccurate as much as 80% of the time, according to a new study. The finding underscores the urgent need for advancements in diagnostic technology ...

The study suggests the tests could save lives by catching cancer at earlier stages, when it's more easily treated. It predicted that, over a decade of use, MCEDs could reduce stage IV cancer diagnoses ...

Late-stage cancer incidence may be a suitable alternative endpoint to cancer-specific mortality in lung and ovarian cancer screening trials, but not in breast, colorectal, or prostate cancer screening ...